Literature DB >> 18726185

Immune mediated neurologic dysfunction as a paraneoplastic syndrome in renal cell carcinoma.

Vijay Johnson1, Norman Friedman, Nairmeen Awad Haller, Christian Hagel.   

Abstract

OBJECTIVE: To describe a case of cerebellar ataxia associated with renal cell carcinoma. CASE REPORT: A 53-year-old Caucasian male with a history of Schizophrenia presented with generalized weakness, nausea, vomiting, severe weight loss, and progressively worsening gait difficulty associated with multiple falls. Physical examination revealed profound ataxia with inability to ambulate despite normal strength. The patient also appeared cachectic. A contrast-enhanced CT of the abdomen/pelvis showed a 10.4 x 8.3 cm(2) left renal mass. Histopathology of the tissue revealed morphology consistent with renal cell carcinoma. Paraneoplastic antibodies including anti-Hu, anti-Ma, anti-Ri, and anti-Yo were negative, however, biotinylated serum analysis was positive for hippocampal and cerebellar Purkinje cells. DISCUSSION: The pathogenesis of paraneoplastic neurological syndromes is believed to be associated with antibody and T-cell mediated response to antigens shared between the tumor and neural tissue. Though serum from this patient was negative for well-characterized antibodies, further testing revealed the presence of proteins binding to the hippocampal region of the midbrain and the cerebellum, and to components of the extracellular matrix of the tumor which may suggest partially characterized or as yet uncharacterized antibodies directed against renal cell tumor tissue and the nervous system. This possibility is supported by the observed symptom resolution upon tumor resection. The described case introduces a possible association between an antibody, which may be specific to paraneoplastic neurological syndromes, and renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726185     DOI: 10.1007/s11060-008-9675-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  9 in total

1.  Paraneoplastic frontal lobe disorder and ataxia in renal cell carcinoma.

Authors:  C Hagel; D Stavrou; H C Hansen
Journal:  Neuropathol Appl Neurobiol       Date:  2005-02       Impact factor: 8.090

2.  Limbic encephalitis as a paraneoplastic manifestation of renal cell carcinoma.

Authors:  B B Bell; P G Tognoni; R Bihrle
Journal:  J Urol       Date:  1998-09       Impact factor: 7.450

3.  Opsoclonus-myoclonus syndrome as a paraneoplastic manifestation of renal cell carcinoma. a case report and review of the literature.

Authors:  S De Luca; C Terrone; S Crivellaro; A De Zan; P Polo; M C Vigliani; A Tizzani
Journal:  Urol Int       Date:  2002       Impact factor: 2.089

Review 4.  Paraneoplastic neurologic syndromes: pathogenesis and physiopathology.

Authors:  J Dalmau; H S Gultekin; J B Posner
Journal:  Brain Pathol       Date:  1999-04       Impact factor: 6.508

5.  Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma.

Authors:  Roberta Vitaliani; Warren Mason; Beau Ances; Theodore Zwerdling; Zhilong Jiang; Josep Dalmau
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

6.  Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer.

Authors:  N E Anderson; M K Rosenblum; F Graus; R G Wiley; J B Posner
Journal:  Neurology       Date:  1988-09       Impact factor: 9.910

7.  Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia.

Authors:  Sabrina Balegno; Mauro Ceroni; Manuel Corato; Diego Franciotta; Bruno Giometto; Kalliope Marinu-Aktipu; Rosanna Nano
Journal:  Anticancer Res       Date:  2005 Sep-Oct       Impact factor: 2.480

8.  Anti-neuronal nuclear autoantibodies, types 1 and 2: their utility in the study of tumors of the nervous system.

Authors:  R H Laeng; B W Scheithauer; H J Altermatt
Journal:  Acta Neuropathol       Date:  1998-10       Impact factor: 17.088

9.  Paraneoplastic limbic encephalitis in Hodgkin's disease.

Authors:  S Deodhare; P O'Connor; D Ghazarian; J M Bilbao
Journal:  Can J Neurol Sci       Date:  1996-05       Impact factor: 2.104

  9 in total
  6 in total

Review 1.  The cerebellum, cerebellar disorders, and cerebellar research--two centuries of discoveries.

Authors:  Mario Manto
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 2.  Rare and changeable as a chameleon: paraneoplastic syndromes in renal cell carcinoma.

Authors:  M Hegemann; N Kroeger; A Stenzl; J Bedke
Journal:  World J Urol       Date:  2018-02-10       Impact factor: 4.226

3.  Paraneoplastic neurological syndromes associated with renal or bladder cancer: case series and PRISMA-IPD systematic review.

Authors:  Macarena Villagrán-García; Sergio Muñiz-Castrillo; Nicolás Lundahl Ciano-Petersen; Alberto Vogrig; Antonio Farina; Marine Villard; Dimitri Psimaras; Agusti Alentorn; David Gonçalves; Nicole Fabien; Véronique Rogemond; Bastien Joubert; Jérôme Honnorat
Journal:  J Neurol       Date:  2022-09-01       Impact factor: 6.682

Review 4.  Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.

Authors:  M Villagrán-García; R Velasco
Journal:  Neurol Sci       Date:  2022-02-17       Impact factor: 3.830

5.  Progressive Global Ataxia With Sensory Changes as a Paraneoplastic Syndrome in a Patient With Chromophobe Renal Cell Carcinoma.

Authors:  Mustafa M Basree; Raquel Rudy; Cristina Romaniello; Daniel E Smith; Elizabeth Kander
Journal:  Cureus       Date:  2022-05-11

6.  Proliferative response of peripheral blood mononuclear cells in anti-Hu antibody-associated patients with paraneoplastic neurological syndrome and their depressant effect on small cell lung cancer cells.

Authors:  Liang Yin; Hongdang Qu; Qiming Chen
Journal:  Mol Med Rep       Date:  2014-11-19       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.